Temple Research Suggests FDA-Approved Drugs Might Prevent Alzheimer’s By Mark TerryMay 3, 2023 The FDA approved Biogen’s Aduhelm (aducanumab) to treat early Alzheimer’s in June of 2021. Then, in 2022, [….]
Temple Research Suggests FDA-Approved Drugs Might Prevent Alzheimer’s
